The pharmaceutical industry is in constant pursuit of innovative treatments, a goal heavily reliant on the synthesis of new and effective drug molecules. Central to this process is the availability of high-quality chemical intermediates, which serve as the foundational components for drug development. 7-Bromo-1H-quinazolin-4-one, identified by its CAS number 194851-16-6, is one such critical compound. NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role in supplying this essential pharmaceutical raw intermediate.

7-Bromo-1H-quinazolin-4-one is a versatile molecule with a distinct chemical structure that lends itself to a multitude of synthetic applications. The quinazolinone core, a fused heterocyclic system, is frequently found in compounds exhibiting diverse biological activities. The addition of a bromine atom at the 7-position provides a convenient site for further chemical modification through various coupling and substitution reactions. This reactivity makes it an ideal starting material for constructing more complex organic molecules that may possess therapeutic properties. Chemists leverage 7-bromo-1h-quinazolin-4-one CAS 194851-16-6 for its predictable chemical behavior and its ability to introduce specific functional groups into target molecules.

The purity of chemical intermediates is a non-negotiable aspect of pharmaceutical manufacturing. NINGBO INNO PHARMCHEM CO.,LTD. ensures that 7-Bromo-1H-quinazolin-4-one is supplied with a minimum purity of 97%, guaranteeing that researchers and manufacturers can rely on its quality for their critical processes. High-purity intermediates minimize side reactions, improve product yields, and ultimately contribute to the safety and efficacy of the final pharmaceutical product. This commitment to quality makes NINGBO INNO PHARMCHEM CO.,LTD. a trusted partner for those in need of specialized organic chemistry intermediates.

The utility of 7-Bromo-1H-quinazolin-4-one as a pharmaceutical intermediate is well-documented. It is employed in the synthesis of various classes of drugs, including those targeting cancer, infectious diseases, and central nervous system disorders. The ability to efficiently modify this scaffold allows for the systematic exploration of structure-activity relationships, a key component of drug discovery. By utilizing such sophisticated building blocks, researchers can accelerate the development of novel therapeutic agents. The strategic use of brominated heterocycles in medicinal chemistry continues to be a fruitful avenue for innovation.

For organizations involved in pharmaceutical research and development, sourcing reliable chemical suppliers is paramount. NINGBO INNO PHARMCHEM CO.,LTD. offers not only high-quality intermediates but also a customer-centric approach. Their expertise in chemical synthesis and a strong supply chain ensure that clients receive the materials they need, when they need them. This reliability is crucial for maintaining project timelines and achieving research objectives. The accessibility of compounds like 7-Bromo-1H-quinazolin-4-one empowers the pharmaceutical industry to bring new medicines to market more efficiently.

In conclusion, 7-Bromo-1H-quinazolin-4-one is an indispensable intermediate in the pharmaceutical landscape. Its chemical versatility and high purity make it an invaluable tool for synthesizing new drug candidates. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing this essential compound, thereby supporting the vital work of pharmaceutical researchers and manufacturers worldwide.